We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $8.17B
1-Year Est. Return 68.82%
This Fund
S&P 500
This Quarter Est. Return
+25.15%
1 Year Est. Return
+68.82%
3 Year Est. Return
+79.68%
5 Year Est. Return
+64.24%
10 Year Est. Return
+259.8%
AUM
$8.17B
AUM Growth
+$2.55B
Cap. Flow
+$12.3M
Cap. Flow %
0.15%
Top 10 Hldgs %
61.52%
Holding
432
New
171
Increased
73
Reduced
69
Closed
99

Top Buys

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$36.5M
2
SUPN icon
Supernus Pharmaceuticals
SUPN
+$36.1M
3
SNY icon
Sanofi
SNY
+$34.1M
4
CYTK icon
Cytokinetics
CYTK
+$31.4M
5
WAT icon
Waters Corp
WAT
+$25.6M

Top Sells

Rank Stock Value
1
TVTX icon
Travere Therapeutics
TVTX
+$147M
2
PTCT icon
PTC Therapeutics
PTCT
+$72.4M
3
IMVT icon
Immunovant
IMVT
+$55.7M
4
DDOG icon
Datadog
DDOG
+$31.8M
5
AVNS
Avanos Medical
AVNS
+$28M

Sector Composition

Rank Sector Weight
1 Miscellaneous 55.89%
2 Healthcare 30.09%
3 Technology 6.58%
4 Consumer Discretionary 3.42%
5 Communication Services 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BSX icon
101
Boston Scientific
BSX
$69.3B
$11.3M 0.14%
+265,201
New +$14.4M
ELF icon
102
e.l.f. Beauty
ELF
$6.47B
$11.3M 0.14%
152,720
+97,294
+176% +$5.91M
NOK icon
103
Nokia
NOK
$56.2B
$11.3M 0.14%
+849,701
New +$10.9M
NPCE icon
104
Neuropace
NPCE
$511M
$11M 0.13%
692,000
– –
NTSK
105
Netskope Inc
NTSK
$5.7B
$10.9M 0.13%
+1,000,000
New +$10.2M
ABNB icon
106
Airbnb
ABNB
$107B
$10.7M 0.13%
74,687
+59,497
+392% +$8.12M
FOXA icon
107
Fox Class A
FOXA
$27.5B
$10.6M 0.13%
+202,892
New +$12.5M
SHAK icon
108
Shake Shack
SHAK
$2.8B
$10.3M 0.13%
+183,118
New +$13.8M
SMTC icon
109
Semtech
SMTC
$13.8B
$10.1M 0.12%
62,380
+489
+0.8% +$63.9K
EOLS icon
110
Evolus
EOLS
$614M
$9.97M 0.12%
1,436,000
+40,000
+3% +$236K
DDOG icon
111
Datadog
DDOG
$76.5B
$9.81M 0.12%
37,679
-170,885
-82% -$31.8M
BBY icon
112
Best Buy
BBY
$19B
$9.67M 0.12%
127,492
+75,861
+147% +$5.04M
ZURA icon
113
Zura Bio
ZURA
$597M
$9.65M 0.12%
1,636,000
+129,000
+9% +$614K
EW icon
114
Edwards Lifesciences
EW
$51.8B
$8.86M 0.11%
97,918
-126,917
-56% -$10.6M
NVDA icon
115
NVIDIA
NVDA
$5.56T
$8.34M 0.1%
41,700
-17,569
-30% -$3.61M
GTLB icon
116
CALL
GitLab
GTLB
$8.3B
$8.24M 0.1%
+270,000
New +$6.85M
PEGA icon
117
Pegasystems
PEGA
$6.14B
$8.22M 0.1%
274,359
+63,930
+30% +$2.29M
BL icon
118
BlackLine
BL
$1.9B
$7.8M 0.1%
278,000
+110,000
+65% +$3.29M
ARMK icon
119
Aramark
ARMK
$15B
$7.74M 0.09%
+136,000
New +$6.71M
RBLX icon
120
Roblox
RBLX
$30.9B
$7.61M 0.09%
139,926
+35,634
+34% +$1.77M
INGN icon
121
Inogen
INGN
$144M
$7.07M 0.09%
1,096,000
-104,000
-9% -$688K
NKE icon
122
Nike
NKE
$57B
$7.01M 0.09%
170,678
-65,862
-28% -$2.9M
SBUX icon
123
Starbucks
SBUX
$119B
$6.96M 0.09%
+68,089
New +$6.86M
XRT icon
124
State Street SPDR S&P Retail ETF
XRT
$359M
$6.91M 0.08%
+78,787
New +$6.64M
APPN icon
125
Appian
APPN
$2.75B
$6.87M 0.08%
+300,000
New +$6.67M
3 4
5
6 7

Similar funds

MWM
Mission Wealth Management Santa Barbara, California $8.18B AUM 28.28% 1-Year Est. Return
BP
Ballentine Partners Waltham, Massachusetts $8.18B AUM 27.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return
SC
Saturna Capital Bellingham, Washington $8.19B AUM 42.01% 1-Year Est. Return
SFM
Soros Fund Management New York $8.14B AUM 35.85% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
BIM
Bridges Investment Management Omaha, Nebraska $8.22B AUM 21.38% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return

Armistice Capital's Q2 2026 Portfolio in Review

As of Q2 2026, Armistice Capital held 432 positions worth $8.17B, up 45% from $5.62B the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Armistice Capital's Q2 2026 filing shows 171 new, 73 increased, 69 reduced and 99 closed positions. Its largest new stake was Waters Corp: 75,004 shares worth $28.1M. The largest sale was Travere Therapeutics, an estimated $147M.

By sector, the portfolio is most concentrated in Miscellaneous at 56% of assets, up from 46% a quarter earlier, followed by Healthcare and Technology.

  • Armistice Capital's largest Q2 2026 buy was Waters Corp: 75,004 shares worth $28.1M.
  • Armistice Capital added most to Regeneron Pharmaceuticals in Q2 2026, an estimated $36.5M increase.
  • Armistice Capital's biggest Q2 2026 reduction was Travere Therapeutics, cutting an estimated $147M.
  • Armistice Capital fully exited Avanos Medical in Q2 2026, selling an estimated $28M.
  • Armistice Capital's ten largest holdings make up 62% of its $8.17B portfolio in Q2 2026.
  • Armistice Capital opened 171 new positions and closed 99 in Q2 2026.
  • Armistice Capital's portfolio value rose 45% quarter-over-quarter to $8.17B.

Based on Armistice Capital's 13F filing for Q2 2026, filed 14 Aug 2026.